A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 clinical trial in adult hypogonadal males with baseline morning serum
testosterone concentrations <300 ng/dL. The purpose of this study is to evaluate the
pharmacokinetics of FE 999303, delivered using an applicator in comparison to hand
application